disulfiram and crizotinib

disulfiram has been researched along with crizotinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Evangelista, M; Merchant, M; Peng, J; Peterson, D; Raha, D; Settleman, J; Wilson, C; Wilson, TR; Yue, P	1

Other Studies

1 other study(ies) available for disulfiram and crizotinib

Article	Year
The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation. Cancer research, 2014, Jul-01, Volume: 74, Issue:13 Topics: Aldehyde Dehydrogenase; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Crizotinib; Disulfiram; DNA Damage; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; Oxidative Stress; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Quinazolines; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Xenograft Model Antitumor Assays	2014

Article

Year

The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation.

Cancer research, 2014, Jul-01, Volume: 74, Issue:13

Topics: Aldehyde Dehydrogenase; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Crizotinib; Disulfiram; DNA Damage; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; Oxidative Stress; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Quinazolines; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Xenograft Model Antitumor Assays

2014